What This Means for the FDA and the Industry -
The COVID-19 pandemic has spurred the development of digital health products utilizing artificial intelligence (AI) and machine learning (ML). When the pandemic passes, there...more
6/25/2021
/ Artificial Intelligence ,
Coronavirus/COVID-19 ,
Digital Health ,
Food and Drug Administration (FDA) ,
Liability ,
Life Sciences ,
Machine Learning ,
Manufacturer Liability ,
Medical Devices ,
Regulatory Oversight ,
Software